Literature DB >> 12491152

The art of survival during viral persistence.

Stephen A Stohlman1, Chandran Ramakrishna, Shuen-Ing Tschen, David R Hinton, Cornelia C Bergmann.   

Abstract

Central nervous system infection by the neurotropic JHM strain of mouse hepatitis virus (JHMV) results in chronic demyelination characterized by viral persistence in the absence of infectious virus. CD8(+) T cells inhibit acute viral replication via cell type-specific effector mechanisms. Perforin-mediated cytolysis controls virus in microglia/macrophages and astrocytes, whereas interferon (IFN)-gamma regulates viral replication in oligodendroglia. JHMV infection of antibody-deficient mice confirmed a primary role of cellular immunity and a redundant role for humoral immunity during acute infection. However, infectious virus reactivates in antibody-deficient mice following viral clearance. This observation suggests that virus-specific T cells in the central nervous system are unable to control viral persistence. Reactivation in antibody-deficient mice is not associated with increased T-cell infiltration, but is prevented via transfer of neutralizing antibody. A vital role for humoral immunity during persistence is supported by the accumulation and retention of virus-specific antibody secreting cells following clearance of infectious virus. Thus, cell-mediated immune responses control acute infection, whereas humoral immunity maintains viral persistence. Therefore, although the central nervous system provides an environment for prolonged retention of both T cells and plasma cells, plasma cells are critical in maintaining persistent virus at undetectable levels. The low turnover of virus, T cells, and B cells constitute a unifying feature of persistent infection, illustrating the dichotomy between distinct immune effectors in regulating acute and persistent central nervous system infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12491152     DOI: 10.1080/13550280290167884

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  5 in total

Review 1.  MicroRNA 155 and viral-induced neuroinflammation.

Authors:  Laura L Dickey; Timothy M Hanley; Thomas B Huffaker; Andrew G Ramstead; Ryan M O'Connell; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2017-01-24       Impact factor: 3.478

2.  MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.

Authors:  Laura L Dickey; Colleen L Worne; Jessica L Glover; Thomas E Lane; Ryan M O'Connell
Journal:  J Neuroinflammation       Date:  2016-09-07       Impact factor: 8.322

Review 3.  Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system.

Authors:  T E Lane; J L Hardison; K B Walsh
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma.

Authors:  Maxim C-J Cheeran; Genya Gekker; Shuxian Hu; Joseph M Palmquist; James R Lokensgard
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

5.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.

Authors:  Minodora O Totoiu; Gabriel I Nistor; Thomas E Lane; Hans S Keirstead
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.